The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Humeau Laurent since 2019.
This trader's CIK number is 1770390.
At the time of last reporting, Humeau Laurent was the Chief Scientific Officer of Inovio Pharmaceuticals, Inc.. (stock ticker symbol INO).
Also see all insider trading activities at Inovio Pharmaceuticals, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | INO | 0 | $0 | 0 | $0 | 8,865 | $0 |
2024 | INO | 0 | $0 | 0 | $0 | 4,771 | $0 |
2023 | INO | 0 | $0 | 0 | $0 | 59,737 | $0 |
2022 | INO | 0 | $0 | 0 | $0 | 139,374 | $0 |
2021 | INO | 0 | $0 | 20,635 | $187,984 | 107,203 | $0 |
2020 | INO | 0 | $0 | 58,400 | $846,959 | 50,279 | $0 |
2019 | INO | 24,500 | $59,990 | 0 | $0 | 5,478 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-02-26 | INO | Option Ex | 8,865 | .00 | 0 |
2024-05-15 | INO | Option Ex | 4,771 | .00 | 0 |
2023-03-11 | INO | Option Ex | 59,737 | .00 | 0 |
2022-03-11 | INO | Option Ex | 59,737 | .00 | 0 |
2022-03-11 | INO | Option Ex | 59,737 | .00 | 0 |
2022-03-08 | INO | Option Ex | 19,900 | .00 | 0 |
2021-08-09 | INO | Sale | 10,317 | 9.15 | 94,400 |
2021-06-09 | INO | Sale | 10,318 | 9.07 | 93,584 |
2021-03-11 | INO | Option Ex | 59,737 | .00 | 0 |
2021-03-05 | INO | Option Ex | 27,566 | .00 | 0 |
2021-03-08 | INO | Option Ex | 19,900 | .00 | 0 |
2020-11-10 | INO | Sale | 19,466 | 9.75 | 189,793 |
2020-08-10 | INO | Sale | 19,467 | 19.06 | 371,002 |
2020-06-22 | INO | Sale | 19,467 | 14.70 | 286,164 |
2020-03-10 | INO | Option Ex | 2,812 | .00 | 0 |
2020-03-08 | INO | Option Ex | 19,900 | .00 | 0 |
2020-03-05 | INO | Option Ex | 27,567 | .00 | 0 |
2019-08-30 | INO | Buy | 4,500 | 2.22 | 9,990 |
2019-06-05 | INO | Buy | 20,000 | 2.50 | 50,000 |
2019-03-09 | INO | Option Ex | 2,666 | .00 | 0 |
2019-03-10 | INO | Option Ex | 2,812 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Humeau Laurent (Chief Scientific Officer of Inovio Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.